𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of the Binding of Ligands to Large Numbers of Sites: The Binding of Tryptophan to the 11 Sites of thetrpRNA-Binding Attenuation Protein

✍ Scribed by H.A. Saroff; J.E. Kiefer


Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
127 KB
Volume
247
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Statistical analysis of computational do
✍ Godden, Jeffrey W.; Stahura, Florence L.; Bajorath, JοΏ½rgen πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 361 KB

The results of 16 docking simulations with rigid receptor sites Ε½ . and flexible ligands ; 60,000 compounds in each case are statistically analyzed and compared. Different combinations of binding sites, scoring functions, and compound collections are used in these calculations. The docking scores ar

On the calculation of the concentration
✍ Leonid M. Berezhkovskiy πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 161 KB πŸ‘ 1 views

The measurement of the unbound drug fraction in plasma is routinely performed at drug concentrations much less than that of plasma proteins. Commonly, the protein has several binding sites of different affinities. The obtained value of the unbound drug fraction does not yield the affinity of each bi

Methods for the analysis of the kinetics
✍ Mary E. Edgerton; Frank A. Handler; Cheng-Wen Wu πŸ“‚ Article πŸ“… 1983 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 786 KB

## Abstract Solutions are obtained that describe the time dependence of the reversible binding of a ligand to a two‐site lattice. The binding may be cooperative. Three methods are used to obtain these solutions: the separation of on/off processes with a variable transformation, the asymptotic serie

A Method for Defining Binding Sites Invo
✍ Gordon Royle; Gary Deng; Dietmar Seiffert; David J. Loskutoff πŸ“‚ Article πŸ“… 2001 πŸ› Elsevier Science 🌐 English βš– 272 KB

Plasminogen activator inhibitor type-1 (PAI-1) is bound to vitronectin (VN) in plasma and in the extracellular matrix. We previously employed a domainswapping approach to show that the high-affinity binding site for PAI-1 in VN is contained within residues 12-30 in the amino-terminal somatomedin B (